|
1
|
Folkman J: Angiogenesis in cancer,
vascular, rheumatoid and other disease. Nat Med. 1:27–31. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Potente M, Gerhardt H and Carmeliet P:
Basic and therapeutic aspects of angiogenesis. Cell. 146:873–887.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gao W, Chang G, Wang J, Jin W, Wang L, Lin
Y, Li H, Ma L, Li Q and Pang T: Inhibition of K562 leukemia
angiogenesis and growth by selective Na+/H+ exchanger inhibitor
cariporide through down-regulation of pro-angiogenesis factor VEGF.
Leuk Res. 35:1506–1511. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Otrock ZK, Mahfouz RA, Makarem JA and
Shamseddine AI: Understanding the biology of angiogenesis: Review
of the most important molecular mechanisms. Blood Cells Mol Dis.
39:212–220. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thairu N, Kiriakidis S, Dawson P and
Paleolog E: Angiogenesis as a therapeutic target in arthritis in
2011: Learning the lessons of the colorectal cancer experience.
Angiogenesis. 14:223–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weis SM and Cheresh DA: Tumor
angiogenesis: Molecular pathways and therapeutic targets. Nat Med.
17:1359–1370. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Folkman J: Angiogenesis: An organizing
principle for drug discovery? Nat Rev Drug Discov. 6:273–286. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Adams RH and Alitalo K: Molecular
regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell
Biol. 8:464–478. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yancopoulos GD, Davis S, Gale NW, Rudge
JS, Wiegand SJ and Holash J: Vascular-specific growth factors and
blood vessel formation. Nature. 407:242–248. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang BH: PI3K/AKT and mTOR/p70S6K1
signaling pathways in human cancer. Curr Cancer Drug Targets.
13:2332013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang BH and Liu LZ: AKT signaling in
regulating angiogenesis. Curr Cancer Drug Targets. 8:19–26. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hoeben A, Landuyt B, Highley MS, Wildiers
H, Van Oosterom AT and De Bruijn EA: Vascular endothelial growth
factor and angiogenesis. Pharmacol Rev. 56:549–580. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen CF, Chiou WF and Zhang JT: Comparison
of the pharmacological effects of Panax ginsengPanax quinquefolium.
Acta Pharmacol Sin. 29:1103–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ng TB: Pharmacological activity of sanchi
ginseng (Panax notoginseng). J Pharm Pharmacol. 58:1007–1019. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Christensen LP: Ginsenosides chemistry,
biosynthesis, analysis, and potential health effects. Adv Food Nutr
Res. 55:1–99. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xie Z, Shi M, Zhang C, Zhao H, Hui H and
Zhao G: Ginsenoside Rd protects against cerebral
ischemia-reperfusion injury via decreasing the expression of the
NMDA receptor 2B subunit and its phosphorylated product. Neurochem
Res. 41:2149–2159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zeng X, Li J and Li Z: Ginsenoside Rd
mitigates myocardial ischemia-reperfusion injury via Nrf2/HO-1
signaling pathway. Int J Clin Exp Med. 8:14497–14504.
2015.PubMed/NCBI
|
|
18
|
Kim BJ: Involvement of melastatin type
transient receptor potential 7 channels in ginsenoside Rd-induced
apoptosis in gastric and breast cancer cells. J Ginseng Res.
37:201–209. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee SY, Kim GT, Roh SH, Song JS, Kim HJ,
Hong SS, Kwon SW and Park JH: Proteome changes related to the
anti-cancer activity of HT29 cells by the treatment of ginsenoside
Rd. Pharmazie. 64:242–247. 2009.PubMed/NCBI
|
|
20
|
Yang ZG, Sun HX and Ye YP: Ginsenoside Rd
from Panax notoginseng is cytotoxic towards HeLa cancer cells and
induces apoptosis. Chem Biodivers. 3:187–197. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park HJ, Zhang Y, Georgescu SP, Johnson
KL, Kong D and Galper JB: Human umbilical vein endothelial cells
and human dermal microvascular endothelial cells offer new insights
into the relationship between lipid metabolism and angiogenesis.
Stem Cell Rev. 2:93–102. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yi T, Yi Z, Cho SG, Luo J, Pandey MK,
Aggarwal BB and Liu M: Gambogic acid inhibits angiogenesis and
prostate tumor growth by suppressing vascular endothelial growth
factor receptor 2 signaling. Cancer Res. 68:1843–1850. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nicosia RF and Ottinetti A: Modulation of
microvascular growth and morphogenesis by reconstituted basement
membrane gel in three-dimensional cultures of rat aorta: A
comparative study of angiogenesis in matrigel, collagen, fibrin,
and plasma clot. In Vitro Cell Dev Biol. 26:119–128. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Malinda KM: In vivo Matrigel migration and
angiogenesis assay. Methods Mol Biol. 467:287–294. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gasparini G, Longo R, Toi M and Ferrara N:
Angiogenic inhibitors: A new therapeutic strategy in oncology. Nat
Clin Pract Oncol. 2:562–577. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fujii T, Yonemitsu Y, Onimaru M, Inoue M,
Hasegawa M, Kuwano H and Sueishi K: VEGF function for upregulation
of endogenous PlGF expression during FGF-2-mediated therapeutic
angiogenesis. Atherosclerosis. 200:51–57. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Semenza GL: Targeting HIF-1 for cancer
therapy. Nat Rev Cancer. 3:721–732. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hay N and Sonenberg N: Upstream and
downstream of mTOR. Genes Dev. 18:1926–1945. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu S, Wu P, Ye D, Huang Y, Zhou X, Li Y
and Cai L: Effects of lipoxin A4 on CoCl2-induced angiogenesis and
its possible mechanisms in human umbilical vein endothelial cells.
Pharmacology. 84:17–23. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Loboda A, Jazwa A, Wegiel B, Jozkowicz A
and Dulak J: Heme oxygenase-1-dependent and -independent regulation
of angiogenic genes expression: Effect of cobalt protoporphyrin and
cobalt chloride on VEGF and IL-8 synthesis in human microvascular
endothelial cells. Cell Mol Biol. 51:347–355. 2005.PubMed/NCBI
|
|
31
|
Ferrara N and Kerbel RS: Angiogenesis as a
therapeutic target. Nature. 438:967–974. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Reuben SC, Gopalan A, Petit DM and
Bishayee A: Modulation of angiogenesis by dietary phytoconstituents
in the prevention and intervention of breast cancer. Mol Nutr Food
Res. 56:14–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Holash J, Wiegand SJ and Yancopoulos GD:
New model of tumor angiogenesis: Dynamic balance between vessel
regression and growth mediated by angiopoietins and VEGF. Oncogene.
18:5356–5362. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lamalice L, Le Boeuf F and Huot J:
Endothelial cell migration during angiogenesis. Circ Res.
100:782–794. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Stotz M, Gerger A, Haybaeck J, Kiesslich
T, Bullock MD and Pichler M: Molecular targeted therapies in
hepatocellular carcinoma: Past, present and future. Anticancer Res.
35:5737–5744. 2015.PubMed/NCBI
|
|
36
|
Holash J, Davis S, Papadopoulos N, Croll
SD, Ho L, Russell M, Boland P, Leidich R, Hylton D, Burova E, et
al: VEGF-Trap: A VEGF blocker with potent antitumor effects. Proc
Natl Acad Sci USA. 99:11393–11398. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ferrara N: Vascular endothelial growth
factor as a target for anticancer therapy. Oncologist. 9 Suppl
1:S2–S10. 2004. View Article : Google Scholar
|
|
38
|
Noble ME, Endicott JA and Johnson LN:
Protein kinase inhibitors: Insights into drug design from
structure. Science. 303:1800–1805. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Radisavljevic Z: AKT as locus of cancer
angiogenic robustness and fragility. J Cell Physiol. 228:21–24.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ciuffreda L, Di Sanza C, Incani UC and
Milella M: The mTOR pathway: A new target in cancer therapy. Curr
Cancer Drug Targets. 10:484–495. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu LZ, Zheng JZ, Wang XR and Jiang BH:
Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis.
Cancer Res. 68:8183–8188. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bhushan S, Kumar A, Malik F, Andotra SS,
Sethi VK, Kaur IP, Taneja SC, Qazi GN and Singh J: A triterpenediol
from Boswellia serrata induces apoptosis through both the intrinsic
and extrinsic apoptotic pathways in human leukemia HL-60 cells.
Apoptosis. 12:1911–1926. 2007. View Article : Google Scholar : PubMed/NCBI
|
